PRDM15 and cancer: By exploring the ongoing DepMap project (22Q2), we have found that PRDM15 is overexpressed in almost all cancer cell lines, particularly in lymphoma cell lines (see Figure 2) and multiple myeloma cancer lines which display relatively higher dependence on PRDM15 compared to other cancer lines (Figure 2B).